Secondary psychoses: an update
Open Access
- 1 February 2013
- journal article
- research article
- Published by Wiley in World Psychiatry
- Vol. 12 (1), 4-15
- https://doi.org/10.1002/wps.20001
Abstract
Psychotic disorders due to a known medical illness or substance use are collectively termed secondary psychoses. In this paper, we first review the historic evolution of the concept of secondary versus primary psychosis and how this distinction supplanted the earlier misleading classification of psychoses into organic and functional. We then outline the clinical features and approach to the diagnosis of secondary psychotic disorders. Features such as atypical presentation, temporal relation to detectable medical cause, evidence of direct physiological causal relationship to the etiological agent, and the absence of evidence of a primary psychotic illness that may better explain the presentation suggest consideration of a secondary psychosis. Finally, we discuss how careful studies of secondary psychotic disorders can help elucidate the pathophysiology of primary, or idiopathic, psychotic disorders such as schizophrenia. We illustrate this issue through a discussion of three secondary psychotic disorders — psychoses associated with temporal lobe epilepsy, velocardiofacial syndrome, and N-methyl D-aspartate (NMDA) receptor encephalitis — that can, respectively, provide neuroanatomical, genetic, and neurochemical models of schizophrenia pathogenesis.This publication has 168 references indexed in Scilit:
- A case of Hashimoto's encephalopathy presenting with seizures and psychosisKorean Journal of Pediatrics, 2012
- Transient psychosis due to painless thyroiditis in a patient with anxiety disorder: a case reportJournal of Medical Case Reports, 2011
- Neuroanatomic Predictors to Prodromal Psychosis in Velocardiofacial Syndrome (22q11.2 Deletion Syndrome): A Longitudinal StudyBiological Psychiatry, 2011
- Early and broadly defined psychosis risk mental statesSchizophrenia Research, 2011
- Alterations of Cortical GABA Neurons and Network Oscillations in SchizophreniaCurrent Psychiatry Reports, 2010
- Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndromePsychiatry Research: Neuroimaging, 2010
- Paraneoplastic syndromes of the CNSThe Lancet Neurology, 2008
- Editors' Introduction: Schizophrenia and ToxoplasmosisSchizophrenia Bulletin, 2007
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007
- Neurocognitive profile in 22q11 deletion syndrome and schizophreniaSchizophrenia Research, 2006